Search research articles
Contact Us
Filters
Showing results (411-420 of 433) with videos related to
Page
of 44
Sort By:
The New England Journal of Medicine
|
June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Michael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Neurology
|
June 3, 2021
Clinical and Genetic Features in Patients With Reflex Bathing Epilepsy
Andrea Accogli, Gert Wiegand, Marcello Scala, et al.
The Lancet. Haematology
|
July 21, 2024
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
William G Wierda, Nirav N Shah, Chan Y Cheah, et al.
Genome Research
|
June 8, 2017
Comprehensive global genome dynamics of <i>Chlamydia trachomatis</i> show ancient diversification followed by contemporary mixing and recent lineage expansion
James Hadfield, Simon R Harris, Helena M B Seth-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, et al.
Neurology
|
July 19, 2022
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
Hannah Stamberger, David Crosiers, Ganna Balagura, et al.
The Lancet. Haematology
|
May 2, 2026
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial
M Lia Palomba, Manish R Patel, Toby A Eyre, et al.
Bipolar Disorders
|
October 21, 2009
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
Hader A Mansour, Michael E Talkowski, Joel Wood, et al.
Nature Immunology
|
May 27, 2022
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Ananda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
Lancet (London, England)
|
June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent, Martin J Landray, Christina Reith, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 433) with videos related to
Sort By:
Page
of 44
The New England Journal of Medicine
|
June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Michael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Neurology
|
June 3, 2021
Clinical and Genetic Features in Patients With Reflex Bathing Epilepsy
Andrea Accogli, Gert Wiegand, Marcello Scala, et al.
The Lancet. Haematology
|
July 21, 2024
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
William G Wierda, Nirav N Shah, Chan Y Cheah, et al.
Genome Research
|
June 8, 2017
Comprehensive global genome dynamics of <i>Chlamydia trachomatis</i> show ancient diversification followed by contemporary mixing and recent lineage expansion
James Hadfield, Simon R Harris, Helena M B Seth-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, et al.
Neurology
|
July 19, 2022
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
Hannah Stamberger, David Crosiers, Ganna Balagura, et al.
The Lancet. Haematology
|
May 2, 2026
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial
M Lia Palomba, Manish R Patel, Toby A Eyre, et al.
Bipolar Disorders
|
October 21, 2009
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
Hader A Mansour, Michael E Talkowski, Joel Wood, et al.
Nature Immunology
|
May 27, 2022
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Ananda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
Lancet (London, England)
|
June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent, Martin J Landray, Christina Reith, et al.
Page
of 44